Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 11576 - 11600 of 12256 in total

R-9-(2-hydroxypropyl)adenine

Experimental
Matched Iupac: … (2R)-1-(6-amino-9H-purin-9-yl)propan-2-ol …

beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide

Experimental
Matched Iupac: … (2S)-1-[(2R)-2-amino-3,3-diphenylpropanoyl]-N-propylpyrrolidine-2-carboxamide …

O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE

Experimental
Matched Iupac: … 4-{[6-(cyclohexylmethoxy)-9H-purin-2-yl]amino}benzene-1-sulfonamide …

D-phenylalanyl-N-benzyl-L-prolinamide

Experimental
Matched Iupac: … (2S)-1-[(2R)-2-amino-3-phenylpropanoyl]-N-benzylpyrrolidine-2-carboxamide …

METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE

Experimental
Matched Iupac: … 2-[(1R)-1-(acetyloxy)-2-methoxy-2-oxoethyl]-5-aminobenzoic acid …

Benfluorex

Benfluorex is an anorectic and hypolipidemic agent that is structurally related to fenfluramine. It was patented and manufactured by a French pharmaceutical company Servier. The European Medicines Agency (EMA) recommended withdrawing all benfluorex containing medicines on 18 December 2009. This recommendation was based on the risks (especially fenfluramine-like cardiovascular side-effects)...
Investigational
Withdrawn
Matched Iupac: … 2-({1-[3-(trifluoromethyl)phenyl]propan-2-yl}amino)ethyl benzoate …

Pavinetant

Pavinetant has been used in trials studying the basic science and treatment of Safety and Schizophrenia.
Investigational
Matched Iupac: … 3-methanesulfonamido-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide …
Matched Categories: … Receptors, Neurokinin-3, antagonists & inhibitors …

8-epi-Cyanocobalamin

Experimental
Matched Iupac: … cobalt(3+) 1-[(2S,3R,4S,5R)-3-hydroxy-4-{[hydroxy({[(2R)-1-({1-hydroxy-3-[(1R,3R,4R,8S,13R,14S,18S,19S ... ]oxy}-5-(hydroxymethyl)oxolan-2-yl]-5,6-dimethyl-3H-1lambda5,3-benzodiazol-1-ylium iminomethanide ... C-hydroxycarbonimidoyl)methyl]-1,4,6,9,9,14,16,19-octamethyl-20,21,22,23-tetraazapentacyclo[15.2.1.1^{2,5}.1^ ... {7,10}.1^{12,15}]tricosa-5(23),6,10(22),11,15(21),16-hexaen-4-yl]propylidene}amino)propan-2-yl]oxy})phosphoryl …

4-Methyl-2,5-dimethoxyamphetamine

A psychedelic phenyl isopropylamine derivative, commonly called DOM, whose mood-altering effects and mechanism of action may be similar to those of LSD.
Experimental
Illicit
Matched Iupac: … 1-(2,5-dimethoxy-4-methylphenyl)propan-2-amine …
Matched Salts cas: … 15589-00-1 …

(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE

Experimental
Matched Iupac: … (2R)-2-(4-chlorophenyl)-2-phenylethan-1-amine …

NAM NAPTHYLAMINOALANINE

Experimental
Matched Iupac: … (2S)-2-amino-3-(naphthalen-1-yl)propanamide …

Propamidine

Experimental
Investigational
Matched Iupac: … 4-[3-(4-carbamimidoylphenoxy)propoxy]benzene-1-carboximidamide …

Sulfatolamide

Experimental
Matched Iupac: … (4-aminobenzenesulfonyl)thiourea; 4-(aminomethyl)benzene-1-sulfonamide …

Parathiazine

Experimental
Matched Iupac: … 10-[2-(pyrrolidin-1-yl)ethyl]-10H-phenothiazine …
Matched Categories: … Heterocyclic Compounds, 3-Ring …

Ephedrine levulinate

Experimental
Matched Iupac: … (1R,2S)-2-(methylamino)-1-phenylpropyl 4-oxopentanoate …

Ethyl piperidinoacetylaminobenzoate

Experimental
Matched Iupac: … ethyl 4-[2-(piperidin-1-yl)acetamido]benzoate …

Olanexidine

Investigational
Matched Iupac: … 1-{N'-[(3,4-dichlorophenyl)methyl]carbamimidamido}-N-octylmethanimidamide …

N-[Tosyl-D-Prolinyl]Amino-Ethanethiol

Experimental
Matched Iupac: … (2R)-1-(4-methylbenzenesulfonyl)-N-(2-sulfanylethyl)pyrrolidine-2-carboxamide …

ZK-805623

Experimental
Matched Iupac: … 2,6-bis(3-carbamimidoylphenoxy)-3,5-difluoro-4-methylpyridin-1-ium …

Talnetant

Talnetant (SB-223,412) is a neurokinin 3 receptor antagonist developed by GlaxoSmithKline, which is being researched for several different functions, primarily for irritable bowel syndrome and as a potential antipsychotic drug for the treatment of schizophrenia.
Investigational
Matched Iupac: … 3-hydroxy-2-phenyl-N-(1-phenylpropyl)quinoline-4-carboxamide …
Matched Description: … Talnetant (SB-223,412) is a neurokinin 3 receptor antagonist developed by GlaxoSmithKline, which is being …
Matched Categories: … Receptors, Neurokinin-3, antagonists & inhibitors …

Chlorsulfaquinoxaline

Chlorsulfaquinoxaline has been used in trials studying the treatment of Lung Cancer and Colorectal Cancer.
Investigational
Matched Iupac: … 4-amino-N-(5-chloroquinoxalin-2-yl)benzene-1-sulfonamide …

Sulfaisodimidine

Sulfaisodimidine also called sulfisomidine is an antibacterial product that has been studied for the treatment of urinary tract infections in the 1950s, however, it is unclear whether this drug has been officially approved for use anywhere .
Experimental
Matched Iupac: … 4-amino-N-(2,6-dimethylpyrimidin-4-yl)benzene-1-sulfonamide …

Clonazoline

Experimental
Matched Iupac: … 2-[(4-chloronaphthalen-1-yl)methyl]-4,5-dihydro-1H-imidazole …

Fepradinol

Experimental
Matched Iupac: … 2-[(2-hydroxy-2-phenylethyl)amino]-2-methylpropan-1-ol …
Matched Salts cas: … 67704-50-1 …

Odanacatib

Odanacatib is an inhibiter of cathepsin K which was originally developed be Merck & Co as a new treatment for osteoporosis . The drug made it to phase III trials before abandoned due to increased stroke.
Investigational
Matched Iupac: … (2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-{[(1S)-2,2,2-trifluoro-1-{4'-methanesulfonyl-[1,1'-biphenyl …
Displaying drugs 11576 - 11600 of 12256 in total